| |
|
|
|
Neos Therapeutics- Inc.  
|
|
6.65 0.15 (0.02%) |
07-13 16:00 |
|
Open: |
6.6 |
Pre close: |
6.5 |
Target:
|
8.23
|
|
High: |
6.94 |
Low: |
6.4 |
Resistance:
|
7.05
8.23
|
|
Volume: |
444,324 |
Market Cap: |
193M |
Support:
|
6.28
5.80
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.37
 |
MACD |
MACD(12,26):
|
-0.13 |
|
MA(20): |
6.34  |
Signal(12,26,9): |
-0.21 |
|
MA(100): |
7.67 |
Stochastic Oscillator |
%K(14,3):
|
68.97 |
|
MA(250): |
8.51 |
%D(3): |
57.42 |
|
Average Volume(K) |
3-Month: |
31073
|
52-Week |
High:
|
13.15 |
|
10-Days: |
24265 |
Low: |
5.80 |
|
RSI |
RSI(14):
|
55.37 |
Change(%): |
-5.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.400 |
Return on Equity (ttm) |
-1568.7 |
Shares Out. (M) |
29.00 |
|
EPS Est. Current Year |
-3.110 |
Return on Assets (ttm) |
-64.6 |
Shares Float (M) |
27.13 |
|
EPS Est. Next Year |
-1.440 |
PEG Ratio |
-0.09 |
% Held by Insiders |
6.40 |
|
EPS Est. Next Quarter |
-0.670 |
Qtrly Rev. Growth |
90.5 |
% Held by Institutions |
53.40 |
|
Forward EPS |
-0.010 |
Gross Profit (p.s.) |
0.228 |
Shares Short (K) |
1863 |
|
Book Value (p.s.) |
30.500 |
EBITDA (p.s.) |
-0.981 |
P/E |
-2.77 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.22 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-50.03 |
P/S |
173738752.00 |
|
Operating Margin |
-180.79 |
Levered Free Cash Flow
(M) |
-29.89 |
P/CF |
-3.85 |
|
|
|
|
|
|
